Company ProfilePremium

Smartac International Holdings Limited

Company Profile Analysis

Ticker: 0395.HK

ESOMAR 23 Corporate BadgeISO Certifications Badge
Smartac International Holdings Limited - Company showcase

Year Founded & Workforce

1977

93 Employees

Smartac International Holdings Limited logo

Smartac International Holdings Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Smartac International Holdings Limited Overview

Smartac International Holdings is a small, Hong Kong-headquartered, Cayman-incorporated investment holding company whose listing on the Hong Kong Main Board was cancelled in February 2023 after nearly two years of suspension for failing to demonstrate a sufficient level of operations under Listing Rule 13.24. Originally floated in 2002 as Asia Zirconium, then the largest zirconium-chemicals exporter in the PRC, the group pivoted over the following decade into mall-focused social CRM and IT services (Smartac), WeChat Pay merchant acquiring in Hong Kong (Haihai Limited), and finally an online-to-offline (O2O) commerce model selling licensed beauty, wellness and fashion brands across Hong Kong and PRC e-commerce platforms. The business never achieved sustained profitability: it posted losses in every year from FY2018 to FY2021, revenue collapsed 73.9% in FY2021 after a supply-chain-trading spike in FY2020, and audit qualifications over receivables and inventory preceded the delisting. It is best characterised today as a delisted micro-cap shell-like holding company with residual trading operations.


Company's own description (latest annual report, FY2021)

According to the FY2021 Annual Report, the company is an investment holding company whose subsidiaries operate in three areas: (i) online-to-offline (O2O) commerce; (ii) electronic payment solutions; and (iii) "others", namely IT system development and support services. Within O2O commerce, management described three activities: commerce solutions for authorised brands spanning online and offline channels; e-tailing solutions for the sale and distribution of branded goods; and customised supply chain management solutions for enterprises. The electronic payment business, run through subsidiary Haihai Limited, provides WeChat Pay merchant access, settlement and marketing functions to Hong Kong merchants. The "others" segment provides tailor-made social CRM platforms and IT support, mainly to PRC shopping-mall operators, property managers and developers, using big-data analysis of consumer behaviour.

The final public update (30 December 2022) narrowed this to O2O commerce and electronic payment solutions, and disclosed new initiatives: sales of a Korean cosmetics brand in the PRC from November 2022 and a planned move into modular energy storage equipment.

Independent characterisation

In substance, the group by FY2020–FY2022 was a brand distributor and trading intermediary rather than a technology company. In FY2020, cost of sales was RMB 169.6 million against revenue of RMB 191.6 million (gross margin 11.5%), consistent with low-margin merchandise trading (supply chain solutions) rather than software or platform fees. The payments and CRM segments, the historic "technology" identity behind the Smartac name, together contributed only about 1.4% of revenue in FY2020 and about 10.2% in FY2021.

Revenue model mix

Revenue typeSegmentDescriptionApprox. share FY2021
Product sales (merchandise)O2O commerceSale of branded beauty, wellness, apparel goods; supply chain trading~89.8%
Commission / transaction feesElectronic payment solutionsFees on WeChat Pay transaction value processed for HK merchants~4.9%
Service / project feesOthersSocial CRM platforms and IT support for PRC malls~5.3%
Subscription / licensing—No subscription or licensing revenue line disclosed—

Source: FY2021 AR segment disclosures; percentages computed from reported segment revenue.

Value chain position, customers, end-markets

Value chain position: Midstream distributor/retailer between overseas brand owners (UK, Israel, Korea, HK-listed supplement makers) and end consumers in Hong Kong and the PRC; also a reseller/agent for Tencent's WeChat Pay in Hong Kong.

Customer types: Retail consumers (HK pop-up stores, Tmall/JD.com flagship stores); enterprise buyers (supply chain solutions); HK merchants in medical/pharmaceutical services, cosmetics and beauty, jewellery, apparel, and food and beverage (payments); PRC mall operators and property developers (CRM).

Concentration: In FY2020 the largest customer was ~12.0% of revenue and the top five ~43.0%; the largest supplier ~18.6% of purchases and the top five ~43.1% (FY2020 AR).

End-markets: PRC cross-border and domestic e-commerce for beauty and health products; Hong Kong physical retail; Hong Kong mobile payments (inbound mainland tourist spending); PRC shopping-mall digital marketing.

Strategy

Stated strategic themes (paraphrased from FY2020–FY2021 Chairman's Statements and Dec 2022 update)

  1. Integrated online-plus-offline one-stop solutions for quality overseas brands, aiming to build a base of high-value customers (FY2020).

  2. Hong Kong as brand incubator, then PRC push — the Grace Cole model (HK pop-ups, then Tmall flagship), to be replicated for other international brands (FY2020).

  3. Focus categories: health supplements and beauty products, citing heightened health awareness after COVID-19 (FY2020–FY2021).

  4. Cost discipline and restructuring — disposing of loss-making subsidiaries, centralising warehousing, redeploying staff, chasing overdue receivables (FY2021).

  5. WeChat Pay recovery on border reopening and helping merchants expand into the Greater Bay Area via WeChat ecosystem tools (FY2020–FY2021).

  6. New verticals — PRC health food (Zhangzhou Keruilin), Korean cosmetics, and modular energy storage equipment (Dec 2022); possible wireless network equipment investment (FY2021).

Initiative register (last 24 months of public disclosure, 2021–2022)

DateInitiativeStatus
Q2 2021Scale-down of supply chain solutions businessExecuted
FY2021Consolidation of eight public warehouses into one self-managed central warehouseExecuted
30 Sep 2021Exit from general merchandise trading (Upfront Success)Completed
4 Nov 2021MOU for health food JVSuperseded by JV agreement
15/29 Nov 2021Health food JV (Zhangzhou Keruilin) formed, 60%Completed
3 Dec 2021Exit from Nutronic fertility-supplement JV (Smartronic)Completed
22 Feb 2022Keruilin made wholly owned (RMB 2M)Completed
Nov 2022Korean cosmetics sales in the PRC; negotiating long-term supply dealRMB 18.35M sales Nov–Dec 2022; long-term deal status unknown
Dec 2022Modular energy storage equipmentAnnounced intention only

Guidance / medium-term targets

No quantitative financial targets or guidance were ever published. Management described itself as "cautiously optimistic" for 2022 (FY2021 AR). ESG commitments with targets: not disclosed.

Products & Services

O2O commerce

OfferingDescriptionTarget customerLaunch / latestPricing model
Grace Cole (UK bath and body)Fragrant bath and body products; HK used as brand incubator for Southeast Asia, then PRC via TmallHK and PRC retail consumersHK pop-ups Oct 2020; Tmall flagship Jan 2021Retail merchandise sales; not disclosed
Mimi Luzon (Israeli skincare)Premium skincare via concept store in an HK department store; store intermittently closed under COVID measuresHK consumersOct 2020Retail; not disclosed
Stella McCartney (luxury fashion)Franchise agreements to sell apparel and accessories in the PRCPRC consumersMar 2020Franchise/merchandise; terms not disclosed
Nutronic fertility supplements (FertiCare, ConcepCare, NatalCare)Exclusive PRC/HK distribution of male and female fertility supplements via Smartronic (51% owned)PRC/HK consumersSep 2020; exited Dec 2021 with Smartronic disposalProduct purchase; annual caps RMB 3.9M (2020), RMB 6.4M (2021), RMB 6.4M (2022); actual 2020 purchases RMB 0.76M
Supply chain management solutionsCustomised procurement/trading for enterprise clientsEnterprises2020; scaled down from Q2 2021Merchandise trading; low margin
General merchandise O2O tradingOnline/offline general merchandise in PRC and HK via Upfront Success groupConsumersDisposed 30 Sep 2021—
Health food (Zhangzhou Keruilin)Marketing, promotion and sale of health food in the PRCPRC consumersNov 2021; wholly owned Feb 2022—
Korean cosmetics brand (unnamed)Sale of popular cosmetic products of a famous Korean brand in the PRC; ~RMB 18.35M sales Nov–Dec 2022PRC consumers / channelsNov 2022Merchandise sales
WeChat merchant digital servicesSet-up of WeChat official accounts, WeChat Malls and mini-programs for merchants, partly under HK Government Distance Business ProgrammeHK merchants2,020—

Electronic payment solutions

OfferingDescriptionTarget customerLaunch / latestPricing
Haihai WeChat Pay acquiringPayment access, settlement and marketing functions offered by WeChat Pay for HK merchants, online and offlineHK merchants serving mainland visitors and localsNot disclosed; active through 2022Commission on transaction value (rates not disclosed)

Others (IT services)

OfferingDescriptionTarget customerLaunch / latestPricing
Social CRM platformTailor-made social membership/CRM platforms using big data to understand shopper behaviour and personalise promotionsPRC shopping-mall operators, property managers, developersLegacy Smartac product; revenue RMB 2.7M in FY2021Project/service fees; not disclosed
IT support servicesSystem development and maintenanceSameOngoing to FY2021—

Announced but not evidenced as launched

  • Modular energy storage equipment and related products (stated plan, 30 Dec 2022 announcement). No revenue, product specification or launch date disclosed.

  • Wireless network equipment investment (mentioned as a possibility in the FY2021 Chairman's Statement).

Legacy (pre-pivot) products — historical only

Zirconium oxychloride, zirconium carbonate, zirconium oxides and other zirconium chemicals; electrode materials for NiMH/NiCd rechargeable batteries; electronic ceramics (PTC heating components, zirconium tiles); nanometric zirconium oxide and cerium-zirconium compound — all under the "Long Jing" trademark (Asia Zirconium AR 2003–2006).

Financial Narrative

All figures RMB million, from the Five-Year Financial Summaries in the FY2020 and FY2021 Annual Reports unless noted. The last audited year is FY2021; no audited FY2022 or later accounts were found (the company was delisted before the FY2022 annual report deadline, and no subsequent publication was located).

Income statement

Notes: FY2019 cost of sales and opex from FY2020 AR MD&A; FY2021 cost of sales derived as revenue minus reported gross profit. FY2017 shows positive EPS despite a group loss, reflecting attribution to non-controlling interests (per the summary as reported). Pre-tax income by year was not separately retrieved for the five-year span.

Margins (%)

Revenue CAGR FY2017–FY2021: ~33.6% (heavily distorted by the one-off FY2020 trading spike; FY2020–FY2021 revenue fell 73.9%). FY2016 revenue was RMB 24.3 million, so revenue over FY2016–FY2021 grew only from RMB 24.3M to RMB 50.1M.

Interim results (unaudited)

Sources: 2021 Interim Report; 2022 Interim Results Announcement (26 Aug 2022). The H1 2021 loss was mainly driven by ~RMB 29.8 million of provisions on trade and other receivables (profit warning, 24 Aug 2021).

Balance sheet

Additional disclosed balance-sheet items: trade receivables RMB 61.4M net at 31 Dec 2020 (of which RMB 42.6M still unsettled at report date); inventories RMB 22.3M net of RMB 9.9M allowance at 31 Dec 2020; investment properties in Suzhou Industrial Park at fair value RMB 57.8M (2020) and RMB 56.5M (2021), pledged; gearing (bank loans plus lease liabilities ÷ total assets) 5.6% (2020) and 8.4% (2021). Distributable reserves: nil at end-2020 and end-2021 (RMB 44.4M at end-2019).

Cash flow

The FY2020 cash decline of ~RMB 166M (with revenue of only RMB 192M and a loss of RMB 57M) indicates heavy working-capital absorption — consistent with the build-up of trade receivables and inventories later impaired. The placing proceeds (HK$257.38M) were fully used by end-FY2021.

Ratios

ROIC, current ratio, interest coverage, net debt/EBITDA and cash conversion cycle: not computable from retrieved data (net debt/EBITDA is not meaningful given negative EBITDA and a net cash position).

Commentary on trends, inflections and drivers

FY2017–FY2019: a cash-rich shell with a sub-scale business. Revenue stayed between RMB 15.7M and RMB 25.8M while the December 2018 placing lifted cash to RMB 252.5M — two-thirds of total assets. Losses of RMB 52–62M a year were driven by administrative costs (RMB 36.1M in FY2019) far exceeding gross profit.

FY2020: the trading spike. Management deployed placing cash into supply-chain trading and e-tailing, multiplying revenue 7.4x to RMB 191.6M but collapsing gross margin to 11.5%. Cash fell RMB 166M. The auditor qualified its opinion because it could not obtain sufficient evidence on the recoverability of receivables from new customers with no credit history, nor on inventory realisable value. This is the critical inflection: revenue growth was bought with working capital that subsequently proved partly unrecoverable.

FY2021: unwind and impairment. Revenue fell 73.9% as supply-chain trading was cut; the trade receivables allowance jumped roughly 20-fold to RMB 19.7M and slow-moving inventory provisions lifted other operating expenses 56% to RMB 15.7M. The loss widened to RMB 96.4M and equity nearly halved to RMB 108.8M. Two loss-making subsidiaries were sold for nominal consideration.

H1 2022: revenue fell further to RMB 15.3M; the operating loss narrowed to RMB 14.5M as cost cuts took hold, but the business remained sub-scale relative to Rule 13.24 expectations.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentWhat it containsKey subsidiaries / brands

O2O commerce

Commerce solutions for authorised brands (online and offline); e-tailing of branded goods; customised supply chain management solutions

Grace Cole, Mimi Luzon, Stella McCartney (PRC franchise), Nutronic (via Smartronic until Dec 2021), Zhangzhou Keruilin (health food, from Nov 2021)

Electronic payment solutions

WeChat Pay merchant access, settlement and marketing in Hong Kong

Haihai Limited

Others

Social CRM platforms and IT support for PRC shopping malls, property managers, developers

Shanghai Shijiexian Network Technology (wholly owned PRC subsidiary; exact segment mapping not disclosed)

O2O commerce

Hong Kong (physical stores, supply chain) and PRC (Tmall/JD.com stores, Stella McCartney franchise, health food, Korean cosmetics)

FY2020/FY2021 AR; 30 Dec 2022 announcement

Electronic payment solutions

Hong Kong only

FY2021 AR

Others (CRM/IT)

PRC only

FY2021 AR

Region revenue (CNY Mn)

FY2019

FY2020

Revenue by Segment

Segment (CNY Mn)FY2019FY2020FY2021

O2O commerce revenue

19.672188.91644.974

Electronic payment solutions revenue

3.4241.9502.436

Others (IT/CRM) revenue

2.7010.7822.673

Total revenue

25.797191.64850.083

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment Margins & Growth (%) and Revenue by Segment (%)

Metric (%)FY2019FY2020FY2021

O2O commerce YoY growth

—860.3-76.2

Electronic payment YoY growth

—-43.024.9

Others YoY growth

—-71.0241.8

O2O share of revenue

76.398.689.8

Electronic payment share of revenue

13.31.04.9

Others share of revenue

10.50.45.3

Income Statement and Per-Share Data

Metric (CNY Mn)FY2017FY2018FY2019FY2020FY2021

Revenue

15.69317.35625.797191.64850.083

Cost of sales

——12.182169.55135.188

Gross profit

——13.61522.09714.895

Selling expenses

——8.93327.56523.613

Administrative expenses

——36.09745.08444.641

Other operating expenses

——1.71810.04315.668

Trade receivables impairment allowance

———0.93619.678

EBIT

-0.134-63.802-59.903-55.517-95.375

EBITDA

14.407-55.222-50.078-50.330-89.594

Loss for the year (group)

-5.666-62.414-52.400-56.950-96.366

EPS basic (MYR Bn)

0.0033-0.0117-0.0067-0.0088-0.0150

EPS diluted (MYR Bn)

0.0033-0.0117-0.0067-0.0088-0.0150

Dividend per share (MYR Bn)

00000

Margin Analysis (%)

Metric (%)FY2017FY2018FY2019FY2020FY2021

Gross margin

——52.811.529.7

EBIT margin

-0.9-367.6-232.2-29.0-190.4

EBITDA margin

91.8-318.2-194.1-26.3-178.9

Net margin

-36.1-359.6-203.1-29.7-192.4

Income Statement

Metric (CNY Mn)H1 2020H1 2021H1 2022

Revenue

53.56235.03215.275

Loss from operations

-16.569-64.535-14.452

Loss before tax

-16.502-61.743-15.368

Loss for the period

-16.476-61.652—

Balance Sheet and Per-Share Data

Metric (CNY Mn)FY2017FY2018FY2019FY2020FY2021

Total assets

246.080377.323322.433255.519163.734

Cash and equivalents incl. pledged deposits

20.551252.459226.37460.46956.797

Total liabilities (derived)

95.60060.26354.01755.91454.953

Net asset value (equity)

150.480317.060268.416199.605108.781

Bank loans total

——9.0008.00010.160

Bank loans due within one year

——9.0008.0000.733

Bank loans due after one year

——0.0000.0009.427

Net cash (cash minus bank loans)

——217.37452.46946.637

NAV per share (MYR Bn)

0.030.060.050.040.02

Ordinary shares (M)

4,762.0335,635.9715,635.9715,635.9715,635.971

Balance Sheet

Metric (CNY Mn)FY2017FY2018FY2019FY2020FY2021

Equity raised (placing, net)

0226.926000

Dividends paid

00000

Share buybacks

00000

Change in cash incl. pledged deposits

—231.908-26.085-165.905-3.672

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2017FY2018FY2019FY2020FY2021

ROE (%, loss ÷ closing NAV)

-3.8-19.7-19.5-28.5-88.6

ROA (%, loss ÷ closing assets)

-2.3-16.5-16.3-22.3-58.9

Asset turnover (x)

0.060.050.080.750.31

Liabilities ÷ equity (x)

0.640.190.200.280.51

Bank debt ÷ equity (x)

——0.030.040.09

Cash ÷ total assets (%)

8.466.970.223.734.7

Capital Markets

ItemDetail

Listing status

Delisted from HKEX Main Board, 20 Feb 2023

Last trading day

31 Mar 2021 (suspended from 1 Apr 2021)

Valuation multiples (P/E, EV/EBITDA, EV/Sales, P/B)

Not applicable; negative earnings and EBITDA in all years FY2018–FY2021

Book value reference

NAV RMB 108.8M (RMB 0.02/share) at 31 Dec 2021

Analyst coverage / consensus

None identified

Dividend history

No dividends for FY2019, FY2020, FY2021; distributable reserves nil at end-2020 and end-2021

Dividend policy

Discretionary, based on performance, liquidity, capital needs, covenants and Cayman law (FY2021 AR)

Buybacks

None disclosed

Equity issuance

812.5M-share placing, Dec 2018 (net HK$257.38M); consideration shares to LCE vendor, Jun 2018

Credit ratings (Moody's/S&P/Fitch)

Not rated

Debt maturity profile

Bank loans RMB 10.16M at end-2021, fixed-rate, RMB-denominated: RMB 0.73M due within one year; RMB 9.43M due after one year; secured on PRC building, Suzhou investment properties, land use rights and a personal guarantee from a subsidiary director

Share count and capital metric

FY2017

Ordinary shares issued (M)

4,762.033

NAV per share (MYR Bn)

0.03

Dividend per share (MYR Bn)

0

Analyst Conclusions

Management guidance

No quantitative guidance was ever issued. The last qualitative outlook (30 Dec 2022) expected significant revenue growth from Korean cosmetics sales through existing O2O channels, benefits from PRC reopening, and expansion into modular energy storage, supported by what management described as abundant financial resources.

Consensus

None. No sell-side coverage exists.

Bull case (grounded in disclosed data)

  1. Asset backing exceeds operating value: RMB 56.8M cash plus RMB 56.5M Suzhou property against total liabilities of ~RMB 55.0M at end-2021 leaves meaningful net tangible value for a private shareholder base.

  2. Revenue traction from Korean cosmetics: RMB 18.35M in just two months (Nov–Dec 2022) suggests the annualised run-rate could exceed FY2021 revenue if sustained.

  3. Post-2023 border reopening: the HK WeChat Pay business was explicitly geared to the return of mainland visitors.

Bear case

  1. Track record of value destruction: cumulative losses of RMB 268M over FY2018–FY2021 and equity down 66% from its FY2018 peak.

  2. Credit and inventory quality: qualified audit, RMB 42.6M of unsettled FY2020 receivables, a 20-fold jump in receivables allowances in FY2021 — evidence that revenue growth was not cash-backed.

  3. No public market or reporting: after delisting, minority shareholders hold unlisted Cayman shares with minimal disclosure and no liquidity; the founder owns only 10.51%, so no controlling shareholder has an obvious incentive to buy out minorities.

Catalysts and monitorables (next 12 months)

  • Any announcement of a privatisation offer, asset sale (e.g., Suzhou properties), liquidation, or relisting attempt.

  • Publication (voluntary or via the Cayman registry) of FY2022–FY2025 accounts.

  • Status of the Korean cosmetics supply agreement and energy storage venture.

  • PRC tax authority action on the LCE Group indirect transfer.

  • Whether the smartacgroup.com website and investor email remain active.

Analyst verdict

Smartac International Holdings is no longer an investable listed security, and the evidence in its own filings explains why. Across two decades the company moved from a genuinely leading niche industrial franchise — Asia Zirconium, once the PRC's largest zirconium chemicals exporter — through a succession of thinly capitalised technology and commerce ventures, none of which reached the scale or profitability needed to justify a Main Board listing. The December 2018 placing gave management roughly HK$257 million to build a durable business. Instead, the capital funded a one-year surge of low-margin supply chain trading in FY2020 that produced headline revenue of RMB 191.6 million but also a qualified audit, large unrecoverable receivables and slow-moving inventory. By FY2021 revenue had fallen back to RMB 50.1 million, losses reached RMB 96.4 million, and equity had dropped to RMB 108.8 million. The Stock Exchange's conclusion that the company did not have sufficient operations under Rule 13.24 was upheld at every level of review, and the listing was cancelled on 20 February 2023.

The residual entity still had tangible assets at its last report — net cash and pledged Suzhou investment properties — and a late burst of Korean cosmetics sales showed that its distribution channels could move product. However, without public reporting, a controlling shareholder, or a liquid market, these assets offer little practical protection to minority holders. Governance signals were consistently weak: repeated INED shortfalls, rapid executive turnover, and a pattern of strategic announcements that preceded rather than followed operating evidence.

For any counterparty, creditor or investor encountering this entity today, the appropriate stance is forensic rather than fundamental: verify current corporate existence and ownership through the Cayman registry, obtain any unpublished FY2022+ accounts directly, and treat all pre-2023 disclosures as historical. On the public record, the verdict is negative: a delisted micro-cap with an unproven business model, no market, and no disclosure.


Key sources (HKEXnews and others):

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenureAge (FY2021 AR)Background / education

Yang Xin Min

Chairman, Executive Director; founding chairman; substantial shareholder

Group GM since Aug 1977; ED re-designation Dec 2020; CEO Apr–Jul 2021

72

Senior economist; 40+ years in zirconium chemicals research, production and international markets; graduate of Beijing Economics Correspondence College; formerly vice chairman of the zirconium branch of the China Nonferrous Metals industry association

Ke Haiwei

Executive Director; Joint CEO (external operations and investment projects)

ED/Joint CEO from 1 Jul 2021; COO Jun–Jul 2021

46

Founder and chairman of Xiamen Zhexin Investment and Xiamen Dingsheng Tianhe Wenhua Chuangyi since 2008; finance and corporate management experience

Wong Wai Wai

Executive Director; Joint CEO (internal control and investment projects)

ED/Joint CEO from 1 Jul 2021; CIO Jun–Jul 2021

39

VP at New China Capital Management (HK) 2006–2019; board observer/senior adviser at Centron Telecom 2009–2017; ED of Anucell Technology 2016–2020; BSc, Chinese University of Hong Kong

Poon Lai Yin Michael

INED; chair of Audit and Remuneration Committees

Since Jan 2010

50

ED and CFO of Huakang Biomedical (8622) since 2017; INED of several HK-listed companies; FCPA (HKICPA), CPA Australia; York University (BA), Monash (MPA)

Wang Haoxian

INED; chair of Nomination Committee

Since 30 Sep 2021

41

Partner, Shenzhen Anpingtai Enterprise Management Consulting (since 2015); accounting degree, Jiangxi University of Finance and Economics

Leung Kwong Choi

INED

———

Hung Ee Tek

CFO and Company Secretary

Since Jul 2021

59

HKICPA and ACCA member; MA International Accounting (CityU HK); MA Global China Studies (HKUST); INED of Xinjiang Tianye Water Saving Irrigation (840)

Board & Management Changes

DateChange

23 Apr 2021

CEO Ho Chi Kin ("Jeff Ho") resigned; Yang Xin Min became Chairman and CEO (deviation from CG Code on role separation)

29 Apr 2021

INEDs Tsui Francis King Chung and Tang Yat Ming Edward resigned

30 Jun 2021

INED Peng Bobo retired (board fell below the INED minimum until 30 Sep 2021)

1 Jul 2021

Ke Haiwei and Wong Wai Wai appointed Joint CEOs; role separation restored

8 Jul 2021

Company secretary/CFO Yeung Wai Ling replaced by Hung Ee Tek

30 Sep 2021

Wang Haoxian appointed INED

31 Dec 2021

INED Dr. Cheng Faat Ting Gary resigned after 20 years (INED count again below Rule 3.10(1) minimum)

2022

Leung Kwong Choi appointed INED (board of six by Dec 2022)

Major Shareholders

HolderShares% of issuedSource

Yang Xin Min (beneficial)

592,573,88010.51

FY2021 AR

Ke Haiwei

30,328,0000.54

FY2021 AR

Wang Haoxian

9,504,0000.16

FY2021 AR

Wong Wai Wai

1,960,0000.03

FY2021 AR

Other 5%+ holders

None disclosed

—

FY2021 AR

Competitive Landscape

Competitors by Segment

SegmentNamed competitorsRelative positioning

Brand e-commerce partner / TP (PRC)

Baozun (NASDAQ: BZUN; HKEX: 9991); Ruoyuchen Technology (SZSE: 003010); Lily & Beauty (SSE: 605136); Yunji (NASDAQ: YJ)

Large-scale operators with hundreds of brand clients; Smartac had a handful of brands

Beauty / wellness retail (HK)

Sa Sa International (HKEX: 178); Bonjour Holdings (historic); A.S. Watson's Watsons and Mannings (Dairy Farm)

Dominant HK chains; Smartac operated five stores at peak

Health supplements distribution (PRC/HK)

By-health (SZSE: 300146); Huakang Biomedical (HKEX: 8622, former partner)

Smartac exited this niche in Dec 2021

WeChat Pay / mobile acquiring (HK)

KPay; Yedpay; AsiaPay; Global Payments; Octopus merchant services

Small reseller among many acquirers

Mall CRM / digital marketing SaaS (PRC)

Mallcoo (猫酷); Tencent smart retail tools; Alibaba Intime/ecosystem tools

Legacy niche, RMB 2.7M revenue in FY2021

Competitor Detail

MetricSmartac (FY2021)

Revenue

RMB 50.1M

Revenue growth

-73.9%

Gross margin

29.7%

Net margin

-192.4%

Recent Developments

After the 20 February 2023 delisting, the company ceased to be subject to HKEX disclosure obligations, and no subsequent press releases, filings or media coverage were located.

Company Snapshot

$7.8M

Revenue

93

Employees

1977

Founded

Causeway Bay, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Net cash position: cash RMB 56.8M versus bank loans RMB 10.2M at 31 Dec 2021 (FY2021 AR).
  • Tangible collateral: Suzhou investment properties at fair value RMB 56.5M (FY2021 AR).
  • Low gearing: 8.4% (bank loans plus leases ÷ total assets) at end-2021.
  • Demonstrated ability to generate trading volume quickly: revenue of RMB 191.6M in FY2020 versus RMB 25.8M in FY2019.
  • Gross margin improvement to 29.7% in FY2021 after exiting low-margin lines (from 11.5%).
  • Late-2022 Korean cosmetics channel: ~RMB 18.35M sales in two months, exceeding H1 2022 total revenue (30 Dec 2022 announcement).

Weaknesses

  • Losses in every year FY2018–FY2021, totalling RMB 268.1M (Five-Year Summary).
  • Qualified audit opinion on FY2020 over receivables (RMB 42.6M unsettled) and inventory (FY2020 AR).
  • Revenue collapse of 73.9% in FY2021 and a further fall to RMB 15.3M in H1 2022.
  • Equity eroded from RMB 317.1M (FY2018) to RMB 108.8M (FY2021).
  • Governance gaps: INED numbers below Rule 3.10(1) minimum twice in FY2021; chair/CEO combined Apr–Jun 2021.
  • Concentration: top five customers ~43% of FY2020 revenue.

Opportunities

  • Mainland–HK border reopening (2023) favouring the WeChat Pay business, as management anticipated.
  • Expansion of the Korean cosmetics relationship into a long-term supply deal (under negotiation, Dec 2022).
  • PRC health food via wholly owned Zhangzhou Keruilin.
  • Modular energy storage diversification (announced intent).
  • Monetisation of Suzhou investment properties to fund operations.
  • Possible future relisting or private transaction using remaining assets — no evidence it is being pursued.

Threats

  • Delisting removes access to public equity and reduces partner credibility (HKEX, Feb 2023).
  • PRC indirect-transfer tax exposure on the 2017 LCE Group acquisition, with penalties of 50%–300% of unpaid tax (FY2021 AR).
  • Intense competition in PRC beauty e-commerce acknowledged by management (FY2021 AR).
  • Further credit losses: receivables allowance jumped about 20-fold in FY2021.
  • FX mismatch: HKD and USD monetary items against an RMB functional base, with no hedging (FY2021 AR).
  • Key-person risk: founder chairman aged 72 at FY2021 holding 10.51%.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
8 Nov 2020Listing Division decides to suspend shares under Rule 6.01(3) for insufficient operations (Rule 13.24)Start of delisting process
17 Dec 2020Yang Xin Min re-designated executive DirectorFounder takes direct executive control
Jan 2021Grace Cole Tmall flagship opensExecution of HK-to-PRC model
23 Feb 2021Listing Committee upholds suspension decisionEscalation
26 Feb 2021Request for Listing Review Committee reviewDefence attempt
30 Mar 2021FY2020 results delayedReporting failure
1 Apr 2021Trading suspended18-month delisting clock begins
23 Apr 2021CEO Ho Chi Kin resignsLeadership instability
29 Apr 2021Two INEDs resignGovernance erosion
7 May 2021LRC review request withdrawnDeadline fixed at 30 Sep 2022
24 May 2021Resumption guidance issued (publish results, address audit modifications, demonstrate Rule 13.24 compliance)Defined remediation path
31 May 2021FY2020 results approved; qualified audit opinionReceivables and inventory concerns crystallise
30 Jun 2021INED Peng Bobo retires; INED count below minimumRule breach
1 Jul 2021Joint CEOs Ke Haiwei and Wong Wai Wai appointedNew management
24 Aug 2021Profit warning: H1 loss ~RMB 61.7M vs RMB 16.5MReceivable provisions ~RMB 29.8M
27 Aug 20212021 interim resultsRevenue RMB 35.0M
30 Sep 2021Upfront Success disposal; Wang Haoxian appointed INEDRestructuring
4 Nov 2021Health food JV MOUNew vertical
15 Nov 2021JV agreement with Xiamen YizhimeiCommitment
3 Dec 2021Smartronic disposalExit from Huakang JV
31 Dec 2021INED Dr. Cheng resigns after 20 yearsGovernance gap
22 Feb 2022Keruilin 40% acquired for RMB 2MFull control of health food unit
25 Mar 2022FY2021 results: revenue -73.9%, loss RMB 96.4MWeak scale evidence
26 Aug 20222022 interim results: revenue RMB 15.3MFurther decline
30 Sep 202218-month resumption deadline expires—
21 Oct 2022Listing Committee decides to cancel listingDelisting decision
24 Oct 2022LRC review requestedFinal appeal
Nov–Dec 2022Korean cosmetics sales ~RMB 18.35MLate revenue push
30 Dec 2022Quarterly update; energy storage plan disclosedLast strategic update
18 Jan 2023LRC upholds delistingAppeal fails
15 Feb 2023Company announces cancellation of listing—
20 Feb 2023Listing cancelledEnd of public company status

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Revenue rose from CNY 15.7 Mn in FY2017 to CNY 50.1 Mn in FY2021.
Smartac International Holdings Limited — Income Statement: Revenue & Gross Profit
Series (CNY Mn)FY2017FY2018FY2019FY2020FY2021
Revenue15.717.425.8191.650.1
Cost of sales——12.2169.635.2
Gross profit——13.622.114.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.